Johnson & Johnson vaccine chart resembles penis, Internet hopes Covid-19 remedy cures 'erectile dysfunction' too
Julia Marcus, an infectious disease epidemiologist and associate professor at Harvard posted the image on Twitter and the responses bordered from serious analysis to wisecracks
Johnson & Johnson, in addition to playing their part inoculating the people of the US in the battle against Covid-19, also gave everyone a reason to go ROFL. The vaccine efficacy chart just looks like a giant penis and an image of that has been doing the rounds on social media.
Julia Marcus, an infectious disease epidemiologist and associate professor at Harvard posted the image on Twitter and the responses that followed were a mix of an analysis of the graph by serious folks while one bunch could just not resist making those wisecracks.
The vaccine was just provided FDA clearance and is a one-shot dose unlike its Pfizer and Moderna counterparts. It also does not require cold storage. The chart highlights the day after receiving the shot where the body adapts by touching a max immunity of 90% against Covid-19 within six weeks.
Studies, according to a Vice report, also say it does give coronavirus a run for its money. So there you go, Johnson and Johnson did more than flip the bird against the virus, it pretty much shafted it too.
Moving on to the reactions then. "Now someone needs to start a viral rumor that it helps with erection and watch the male half of America get 100% vaccinated in no time," read one of the tweets. A quick response to this followed: "Covid has been linked to erectile dysfunction, so indirectly, your statement is actually true!"
The one-liners weren't far behind. "Gotta love hard data," read a comment. Perceptions followed: "It looks like a diving board if a diving board was a gigantic cock," one user said.
Now someone needs to start a viral rumor that it helps with erection and watch the male half of America get 100% vaccinated in no time.— Alex Pryrodny (@rurikbird) March 3, 2021
Covid has been linked to erectile dysfunction, so indirectly, your statement is actually true!— Owned by Dogs (@TheseDogsownme) March 4, 2021
Gotta love hard data 😉— Anuraag Saxena (@anuraag_saxena) March 3, 2021
It looks like a diving board if a diving board was a gigantic cock.— Tony Posnanski (@tonyposnanski) March 3, 2021
"It kinda looks like a type of coat hook, but then...so does a [eggplant emoji]," one user remarked. The double entendres just seemed to never end. "Nice to see J&J ball out, hard to deny their results. Looks like these other companies are getting the shaft," a tweet read. "The developers of the vaccine must be swelling with pride," said another.
🤣😂❤️— Sad, but Hopeful (@Sh3rrySt0ut) March 3, 2021
It kinda looks like a type of coat hook, but then...so does a 🍆.
Nice to see J&J ball out, hard to deny their results. Looks like these other companies are getting the shaft.— Jeff Kotuby 🏴☠️ (@JeffKotuby) March 3, 2021
The developers of the vaccine must be swelling with pride.— julian sheppard (@JxSheppard) March 3, 2021
Previously, we had reported on the effectiveness of the J&J vaccine. According to researchers, it was 85.4% effective at preventing severe cases of Covid-19. The FDA concluded that the Johnson & Johnson vaccine has “known benefits” in reducing both symptomatic and severe illnesses. This was the third Covid-19 vaccine that could be authorized for emergency use in the US after Pfizer and Moderna.
“Safety analysis through the January 22, 2021 data cutoff included 43,783 randomized participants 18 years of age and older with 2-month median follow-up. The analysis supported a favorable safety profile with no specific safety concerns identified that would preclude the issuance of an EUA,” says the 62-page document.
It added: “Analyses of secondary endpoints demonstrated vaccine efficacy against central laboratory-confirmed and blind-adjudicated severe/critical Covid-19 occurring at least 14 days and at least 28 days after vaccination of 76.7% and 85.4% respectively.”